Crossmark

Alpha-enolase (ENO1), identified as an antigen to monoclonal antibody 12C7, promotes the self-renewal and malignant phenotype of lung cancer stem cells by AMPK/mTOR pathway

Crossref DOI link: https://doi.org/10.1186/s13287-021-02160-9

Published Online: 2021-02-12

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shu, Xiong

Cao, Kai-Yue

Liu, Hui-Qi

Yu, Long

Sun, Li-Xin

Yang, Zhi-Hua

Wu, Cheng-Ai

Ran, Yu-Liang
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82073278, 81330043)

National Key R&D Program of China (2017YFC1308700)

CAMS Innovation Fund for Medical Sciences (2016-I2M-3-013)

Beijing Municipal Commission of Education (BMC2018-4)

Beijing Municipal Health Commission (BMC2019-9)

Natural Science Foundation of Beijing JiShuiTan Hospital (ZR-201906)
License Information

Text and Data Mining valid from 2021-02-12

Version of Record valid from 2021-02-12
More Information

Article History

Received: 14 July 2020

Accepted: 12 January 2021

First Online: 12 February 2021

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below